Myostatin and plasticity of skeletal muscle tissue
Keywords:
Myostatin, Skeletal muscle plasticity, Myokines, Physical activityAbstract
Skeletal muscle is an extremely plastic tissue for its ability to respond to different stimuli such as physiological variation and external stress. Muscle hypertrophy involves an increase in muscle mass, changes in myofibril composition and adaptation of metabolic pathways. Plasticity of skeletal muscle in response to exercise training is also caused by proliferation and differentiation of the satellite muscle stem cells in response to various growth and differentiation factors. This process is mainly mediated by myokines secreted during skeletal muscle contraction. Myokines are proteins that act as hormones both locally in the muscle and/or in an endocrine manner in other organs, mainly liver, brain and adipose tissue. Myostatin, known as growth differentiation factor-8, a myokine member of transforming growth factor-b (TGF-b) superfamily, can act on muscle cells in an autocrine manner leading to inhibition of muscle myogenesis. Muscle myostatin expression and its plasma concentration are downregulated after acute and long-term physical exercise thus allowing muscle hypertrophy. In addition, myostatin is correlated to obesity and insulin resistance for its ability to affect energy metabolism and insulin-sensitivity in muscle cells, respectively. These findings reveal that myostatin may have potential therapeutic applications to treat muscle atrophy diseases in humans. Even in sports, drugs able to inhibit myostatin expression can lead athletes to increase their sport performance. Here, we present a brief overview of myostatin and its role in biological mechanisms involved in exercise-induced plasticity of skeletal muscle.Downloads
References
Adornetto A, Pagliara V, Renzo GD, Arcone R. (2013) Polychlorinated biphenyls impair dibutyryl cAMP-induced astrocytic differentiation in rat C6 glial cell line. FEBS Open Bio 3, 459-466.
https://doi.org/10.1016/j.fob.2013.10.008
Allen DL, Hittel DS, McPherron AC. (2011) Expression and function of myostatin in obesity, diabetes and exercise adaptation. Med. Sci. Sports Exerc. 43, 1828‐1835. https://doi.org/10.1249/mss.0b013e3182178bb4
Artaza JN, Bhasin S, Magee TR, Reisz-Porszasz S, Shen R, Groome NP, Meerasahib MF, Gonzalez-Cadavid NF. (2005) Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146, 3547-3557. https://doi.org/10.1210/en.2005-0362
Bazgir B, Fathi R, Valojerdi MR, Mozdziak P, and Asgari A. (2017) Satellite Cells Contribution to Exercise Mediated Muscle Hypertrophy and Repair. Cell J. 18, 473-484.
Bodine SC. (2013) Disuse-induced muscle wasting. Int. J. Biochem. Cell Biol. 45, 2200-2208.
Cotton TR, Fischer G, Wang X, McCoy JC, Czepnik M, Thompson TB, Hyvönen M. (2018) Structure of the human myostatin precursor and determinants of growth factor latency. EMBO J. 37, 367-383. https://doi.org/10.15252/embj.201797883
Deng B, Zhang F, Wen J, Ye S, Wang L, Yang Y, Gong P, Jiang S. (2017) The function of myostatin in the regulation of fat mass in mammals. Nutr. Metab. (Lond) 14, 29. https://doi.org/10.1186/s12986-017-0179-1
Desplanches D. (1997) Structural and functional adaptations of skeletal muscle to weightlessness. Int. J. Sports Med. 18 Suppl. 4, S259-S264. https://doi.org/10.1055/s-2007-972722
Dong L. (2019) IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway. Skeletal Muscle, 9, 8. https://doi.org/10.1186/s13395-019-0193-2
Drevon CA and Norheim F. (2016) Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells. Acta Physiol. 217, 45-60. https://doi.org/10.1111/apha.12631
Hansen J, Brandt C, Nielsen AR, Hojman P, Whitham M, Febbraio MA, Pedersen BK, Plomgaard P. (2011) Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine. Endocrinology 152, 164-171. https://doi.org/10.1210/en.2010-0868
Hittel DS, Axelson M, Sarna N, Shearer J, Huffman KM, and Kraus WE. (2010) Myostatin decreases with aerobic exercise and associates with insulin resistance. Med. Sci. Sports Exerc. 42, 2023-2029. https://doi.org/10.1249/mss.0b013e3181e0b9a8
Hoppeler H, Klossner S, Vogt M. (2008) Training in hypoxia and its effects on skeletal muscle tissue. Scand. J. Med. Sci. Sports 18 Suppl. 1, 38-49. https://doi.org/10.1111/j.1600-0838.2008.00831.x
Hoppeler H, Baum O, Lurman G, Mueller M. (2011) Molecular mechanisms of muscle plasticity with exercise. Compr. Physiol. 1, 1383-1412. https://doi.org/10.1002/cphy.c100042
Konopka AR, Wolff CA, Suer MK, Harber MP. (2018) Relationship between intermuscular adipose tissue infiltration and myostatin before and after aerobic exercise training. Am. J. Physiol. Regul. Integr. Comp. Physiol. 315, R461-R468. https://doi.org/10.1152/ajpregu.00030.2018
Kumar V, Selby A, Rankin D, Patel R, Atherton P, Hildebrandt W, et al. (2009) Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J. Physiol. 587, 211-217. https://doi.org/10.1113/jphysiol.2008.164483
Lee S, and McPherron AC. (2018) Structure of the human myostatin precursor and determinants of growth factor latency. EMBO J. 3, 367-383.
Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA. (2002) Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem. Biophys. Res. Commun. 291, 701-706. https://doi.org/10.1006/bbrc.2002.6500
Liu D, Qiao X, Ge Z, Shang Y, Li Y, Wang W, Chen M, Si S, Chen SZ. (2019) IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway. Skeletal Muscle 9, 8. https://doi.org/10.1186/s13395-019-0193-2
Lee JH, Jun HS. (2019) Role of Myokines in Regulating Skeletal Muscle Mass and Function. Front Physiol. 10, 42. https://doi.org/10.3389/fphys.2019.00042
Louis E, Raue U, Yang Y, Jemiolo B, and Trappe S. (2007) Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J. Appl. Physiol. 103, 1744-1751. https://doi.org/10.1152/japplphysiol.00679.2007
Maltais ML, Perreault K, Courchesne-Loyer A, Lagacé JC, Barsalani R, Dionne IJ. (2016) Effect of Resistance Training and Various Sources of Protein Supplementation on Body Fat Mass and Metabolic Profile in Sarcopenic Overweight Older Adult Men: A Pilot Study. Int. J. Sport. Nutr. Exerc. Metab. 26, 71-77. https://doi.org/10.1123/ijsnem.2015-0160
Mazzeo F, and Raiola G. (2018) An investigation of drugs abuse in sport performance. Journal of Human Sport and Exercise 13, S309-S319. https://doi.org/10.14198/jhse.2018.13.proc2.15
McPherron, AC and Lee SJ. (1997) Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA 94, 12457-12461. https://doi.org/10.1073/pnas.94.23.12457
McPherron AC, Lawler AM, Lee SJ. (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta super-family member. Nature 387, 83-90. https://doi.org/10.1038/387083a0
McPherron AC, Lee SJ. (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin. Invest. 109, 595-601. https://doi.org/10.1172/jci200213562
Mero AA, Hulmi JJ, Salmijärvi H, Katajavuori M, Haverinen M, Holviala J, et al. (2013) Resistance training induced increase in muscle fiber size in young and older men. Eur. J. App,l Physiol. 113, 641-650. https://doi.org/10.1007/s00421-012-2466-x
Negaresh R, Ranjbar R, Baker JS, Habibi A, Mokhtarzade M, Gharibvand MM, Fokin A. (2019) Skeletal Muscle Hypertrophy, Insulin-like Growth Factor 1, Myostatin and Follistatin in Healthy and Sarcopenic Elderly Men: The Effect of Whole-body Resistance Training. Int. J. Prev. Med. 5, 10-29. https://doi.org/10.21859/sija-120154
Palsgaard, J, Brons C., Friedrichsen M, Dominguez H, Jensen M, Storgaard H, Spohr C, Torp-Pedersen C, Borup R, De Meyts P, Vaag A. (2009) Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signalling pathways. PLoS ONE 4, e6575. https://doi.org/10.1371/journal.pone.0006575
Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP (2006) GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol. Genomic 27, 114-121. https://doi.org/10.1152/physiolgenomics.00045.2006
Pedersen BK, Akerstrom TC, Nielsen AR and Fischer CP. (2007). Role of myokines in exercise and metabolism. J. Appl. Physiol. 103, 1093-1098. https://doi.org/10.1152/japplphysiol.00080.2007
Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee S. (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. New Engl. J. Med. 50, 2682-2688. https://doi.org/10.1056/nejmoa040933
Tamura K, Furuichi Y, Manabe Y, Fujii NL. (2017) Role of satellite cells in skeletal muscle plasticity: beyond muscle regeneration. J. Phys. Fitness Sports Med. 6, 89-93. https://doi.org/10.7600/jpfsm.6.89
Vitucci D, Imperlini E, Arcone R, Alfieri A, Canciello A, Russomando L, Martone D, Cola A, Labruna G, Orrù S, Tafuri D, Mancini A, Buono P. (2018) Serum from differently exercised subjects induces myogenic differentiation in LHCN-M2 human myoblasts. J. Sports Sci. 36, 1630-1639.
Vogt M, Puntschart A, Howald H, Mueller B, Mannhart C, Gfeller- Tuescher L, Mullis P, Hoppeler H. (2003) Effects of dietary fat on muscle substrates, metabolism, and performance in athletes. Med. Sci. Sports Exerc. 35, 952-960. https://doi.org/10.1249/01.mss.0000069336.30649.bd
Downloads
Statistics
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Journal of Human Sport and Exercise
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Each author warrants that his or her submission to the Work is original and that he or she has full power to enter into this agreement. Neither this Work nor a similar work has been published elsewhere in any language nor shall be submitted for publication elsewhere while under consideration by JHSE. Each author also accepts that the JHSE will not be held legally responsible for any claims of compensation.
Authors wishing to include figures or text passages that have already been published elsewhere are required to obtain permission from the copyright holder(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Please include at the end of the acknowledgements a declaration that the experiments comply with the current laws of the country in which they were performed. The editors reserve the right to reject manuscripts that do not comply with the abovementioned requirements. The author(s) will be held responsible for false statements or failure to fulfill the above-mentioned requirements.
This title is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license (CC BY-NC-ND 4.0).
You are free to share, copy and redistribute the material in any medium or format. The licensor cannot revoke these freedoms as long as you follow the license terms under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
Transfer of Copyright
In consideration of JHSE’s publication of the Work, the authors hereby transfer, assign, and otherwise convey all copyright ownership worldwide, in all languages, and in all forms of media now or hereafter known, including electronic media such as CD-ROM, Internet, and Intranet, to JHSE. If JHSE should decide for any reason not to publish an author’s submission to the Work, JHSE shall give prompt notice of its decision to the corresponding author, this agreement shall terminate, and neither the author nor JHSE shall be under any further liability or obligation.
Each author certifies that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article, except as disclosed on a separate attachment. All funding sources supporting the Work and all institutional or corporate affiliations of the authors are acknowledged in a footnote in the Work.
Each author certifies that his or her institution has approved the protocol for any investigation involving humans or animals and that all experimentation was conducted in conformity with ethical and humane principles of research.
Competing Interests
Biomedical journals typically require authors and reviewers to declare if they have any competing interests with regard to their research.
JHSE require authors to agree to Copyright Notice as part of the submission process.
